Chemistry Reference
In-Depth Information
28. Chermesh, I. and Eliakim, R., Probiotics and the gastrointestinal tract: Where we are in
2005? World J. Gastroenterol., 12,853,2006.
29. Schroder, O., Gerhard, R., and Stein, J., Antibiotic-associated diarrhea. J. Gastroenterol.,
44,193,2006.
30. Bergogne-Berezin, E., Treatment and prevention of antibiotic associated diarrhea, Int. J.
Antimicrob. Agents, 16,521,2000.
31. McFarland, L.V., Surawicz, C.M., and Greenberg, R.N., Prevention of beta-lactam
associated diarrhoea by Saccharomyces boulardii compared with placebo. Am. J.
Gastroenterol., 90,439,1995.
32. Madden, J.A., Plummer, S.F., and Tang, J., Effect of probiotics on preventing disrup-
tion of the intestinal microflora following antibiotic therapy: A double-blind, placebo-
controlled pilot study, Int. Immunopharmacol., 5,1091,2005.
33. Vanderhoof, J.A. et al., Lactobacillus GG in the prevention of antibiotic-associated diar-
rhoea in children, J. Pediatr., 135,535,1999.
34. D'Souza, AL, R.C., Cooke, J., and Bulpitt, CJ., Probiotics in prevention of antibiotic
associated diarrhoea: Meta-analysis, Br. Med. J., 324,1361,2002.
35. Wenus, C. et al., Prevention of antibiotic-associated diarrhoea by a fermented probiotic
milk drink, Eur. J. Clin. Nutr., 62,299,2008.
36. Delia, P. et al., Use of probiotics for prevention of radiation-induced diarrhea, World J.
Gastroenterol., 13,912,2007.
37. Demirer, S. et al., Effects of probiotics on radiation-induced intestinal injury in rats,
Nutrition, 22,179,2006.
38. Urbancsek, H. et al., Results of a double blind, randomized study to evaluate the effi-
cacy and safety of L . acidophilus in patients with radiation induced diarrhea, Eur. J.
Gastroenterol. Hepatol., 13,391,2001.
39. Surowiec, D. et al., Past, present, and future therapies for Clostridium difficile -associ-
ated disease, Ann. Pharmacother., 40,2155,2006.
40. Halsey, J., Current and future treatment modalities for Clostridium difficile -associated
disease. Am. J. Health Syst. Pharm., 65,705,2008.
41. Posani, T., Clostridium difficile : Causes and interventions, Crit. Care Nurs. Clin. North
Am., 16,547,2004.
42. McFarland, L.V., Surawicz, C.M., and Greenberg, R.N., A randomized placebo con-
trolled trial of Saccharomyces boulardii in combination with standard antibiotics for
Clostridium difficile disease, JAMA, 271,1913,1994.
43. McFarland, LV., Meta-analysis of probiotics for the prevention of traveler's diarrhea,
Travel Med. Infect. Dis., 5,97,2007.
44. Pham, M., Lemberg, D.A., and Day, A.S., Probiotics: Sorting the evidence from the
myths, Med. J. Aust., 188,304,2008.
45. Hilton, E. et al., Efficacy of Lactobacillus GG as a diarrhoeal preventive in travelers, J.
Travel. Med. , 4,41,1997.
46. Ericsson, C.D.., Nonantimicrobial agents in the prevention and treatment of traveler's
diarrhea, Clin. Infect. Dis., 41,S557,2005.
47. Chouraqui, J.P. et al., Assessment of the safety, tolerance, and protective effect against
diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiot-
ics in a randomized controlled trial, Am. J. Clin. Nutr., 87,1365,2008.
48. Isolauri, E. et al., A human Lactobacillus strain ( L. casei sp. strain GG) promotes recov-
ery from acute diarrhoea in children, Pediatrics, 88,90,1991.
49. Kaila, M. et al., Enhancement of the circulating antibody secreting cell response in
human diarrhoea by a human Lactobacillus strain, Pediatr. Res., 32,141,1992.
Search WWH ::




Custom Search